Iede K, Yamada T, Koh M, Ueda M, et al. Optimal Relative Dose Intensity in the First 4 Weeks During Nab-Paclitaxel Plus Gemcitabine for Older Patients With Advanced Pancreatic Cancer in Japan. Pancreas 2022;51:e4-e6.
PMID: 35195606